ICON Public Limited (NASDAQ:ICLR) Short Interest Update

ICON Public Limited (NASDAQ:ICLR) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 1,390,000 shares, a decline of 13.7% from the January 15th total of 1,610,000 shares. Approximately 1.7% of the shares of the company are short sold. Based on an average daily trading volume, of 1,130,000 shares, the days-to-cover ratio is presently 1.2 days.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on ICLR shares. The Goldman Sachs Group dropped their price objective on shares of ICON Public from $370.00 to $280.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Royal Bank of Canada restated an “outperform” rating and set a $263.00 target price on shares of ICON Public in a research report on Wednesday, January 15th. William Blair restated an “outperform” rating on shares of ICON Public in a research report on Tuesday, January 14th. Leerink Partners restated an “outperform” rating and set a $255.00 target price (down from $270.00) on shares of ICON Public in a research report on Tuesday, November 19th. Finally, Truist Financial decreased their target price on shares of ICON Public from $284.00 to $262.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Four analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $283.92.

ICON Public Trading Up 2.0 %

Shares of ICON Public stock opened at $186.21 on Tuesday. The firm has a 50-day simple moving average of $204.18 and a two-hundred day simple moving average of $247.73. The company has a market cap of $15.36 billion, a P/E ratio of 20.76, a price-to-earnings-growth ratio of 1.78 and a beta of 1.19. ICON Public has a fifty-two week low of $181.51 and a fifty-two week high of $347.72. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.34 and a current ratio of 1.34.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ICLR. Sierra Ocean LLC acquired a new position in shares of ICON Public during the 4th quarter worth about $29,000. Park Place Capital Corp raised its position in shares of ICON Public by 281.4% during the 4th quarter. Park Place Capital Corp now owns 225 shares of the medical research company’s stock worth $47,000 after purchasing an additional 166 shares during the last quarter. Private Trust Co. NA raised its position in shares of ICON Public by 48.8% during the 4th quarter. Private Trust Co. NA now owns 250 shares of the medical research company’s stock worth $52,000 after purchasing an additional 82 shares during the last quarter. GAMMA Investing LLC raised its position in shares of ICON Public by 64.0% during the 4th quarter. GAMMA Investing LLC now owns 433 shares of the medical research company’s stock worth $91,000 after purchasing an additional 169 shares during the last quarter. Finally, Horizon Investments LLC raised its position in shares of ICON Public by 534.0% during the 4th quarter. Horizon Investments LLC now owns 653 shares of the medical research company’s stock worth $137,000 after purchasing an additional 550 shares during the last quarter. Institutional investors and hedge funds own 95.61% of the company’s stock.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.